The University of Utah is recruiting multiple faculty members to expand its research strength in digital health applications specifically related to physical activity, nutrition, diabetes, obesity, and metabolic health.
The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart disease-related death by 20% in a major clinical trial in people with cardiovascular
The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart disease-related death by 20% in a major clinical trial in people with cardiovascular disease, the first to show a weight loss drug alone can have such protective effects.
The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in a clinical trial in people with cardiovascular disease.
The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart disease-related death by 20% in a major clinical trial in people with cardiovascular